Company intelligence / Profile preview
IDEOGEN
Hurden, Schwyz, Switzerlandideogen.com ↗
- Ownership
- Private
- Employees
- ~49
- Development stage
- Commercial
01
Overview
IDEOGEN specializes in the global commercialization of specialty medicines addressing unmet medical needs. The company provides access to both original brands and complex generics across oncology, hematology, rare diseases, supportive care products, FSMPs, and cosmeceuticals. It operates programs such as name patient programs for orphan indications but does not appear to conduct its own clinical trials or develop new molecular entities. Its business model centers on market access solutions rather than drug discovery or early-stage development.
- Therapeutic areas
- OncologyRare DiseasesOther
- Modalities
- Small moleculesGenerics and branded specialty medicinesCosmeceuticalsFood for special medical needs (FSMP)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on IDEOGEN.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IDEOGEN.